| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $184.4M | +404.5% |
| R&D Expense | $137.9M | +54.7% |
| SG&A Expense | $67.1M | +37.5% |
| Operating Income | -$20.6M | +79.7% |
| Interest Expense | $9K | -65.4% |
| Income Tax | $0 | — |
| Net Income | -$6.9M | +92.3% |
| EPS (Basic) | -$0.12 | +92.7% |
| EPS (Diluted) | -$0.12 | +92.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.2M | -34.2% |
| Accounts Receivable | $5.9M | +255.9% |
| Current Assets | $305.7M | +31.3% |
| Total Assets | $418.4M | +54.1% |
| Current Liabilities | $57.9M | +44.5% |
| Total Liabilities | $66.0M | +55.1% |
| Stockholders' Equity | $352.5M | +53.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $45.6M | +152.5% |
| Capital Expenditures | $670K | +230.0% |
| Investing Cash Flow | -$186.8M | -73.8% |
| Financing Cash Flow | $97.4M | -25.7% |
| Free Cash Flow | $44.9M | +151.6% |